← All trials
NCT00908401
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 30, 2009
- Primary completion
- Jul 31, 2009
- Completion date
- Jul 31, 2009
- First posted
- May 25, 2009
- Last posted
- May 25, 2009
- Enrollment
- 42
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Centre Hospitalier Intercommunal CreteilLead sponsor
- Centre Hospitalier Intercommunal CreteilOverall official - principal investigator
- Centre Hospitalier Intercommunal CreteilOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.